🇧🇪 Belgium Country × Condition
ovarian cancer Clinical Trials in Belgium
Active clinical trials for ovarian cancer with research sites in Belgium. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2, Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇧🇪 Belgium
Active Trials in Belgium (2)
NCT06906341 Phase 2
Recruiting
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Enrollment
270 pts
Country
🇧🇪 Belgium
Corcept Therapeutics
View Trial → NCT06303505 Phase 1, Phase 2
Recruiting
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Enrollment
250 pts
Country
🇧🇪 Belgium
Tubulis GmbH
View Trial → Frequently Asked Questions
How many ovarian cancer clinical trials are active in Belgium?
There are currently 2 active clinical trials for ovarian cancer with sites in Belgium, of which 2 are actively recruiting patients.
How can I join a ovarian cancer clinical trial in Belgium?
To join a ovarian cancer clinical trial in Belgium, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Belgium directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are ovarian cancer trials in Belgium?
Active ovarian cancer trials in Belgium span Phase 2, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology